Motor & Autonomic Concomitant Health Improvements With Neuromodulation & Exercise Training: An SCI RCT

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 22, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Spinal Cord InjuriesNeurogenic BladderNeurogenic Bowel
Interventions
DEVICE

Transcutaneous Spinal Cord Stimulation

Therapeutic TSCS will be delivered during ABT using a non-invasive central nervous system stimulator (TESCoN, SpineX Inc., CA, USA). Stimulation will involve charge balanced monophasic rectangular waveforms with 1.0-ms pulses, administered at 30 Hz, with a carrier frequency of 10 kHz and a current ranging from 10 to 130 mA.

DEVICE

SHAM (low-intensity) Transcutaneous Spinal Cord Stimulation

Ineffective stimulation will be administered at the same anatomical location as therapeutic TSCS.

DEVICE

Activity-Based Therapy

"Using BWSTT, all participants (both arms) will train 3 times per week for 12 weeks with a target to reach 45 minutes of gait training in each session.~For gait training, the level of body weight support and speed of walking will be adjusted to allow the person to bear as much weight as possible while maintaining proper stance limb kinematics."

Trial Locations (1)

V5Z 1M9

RECRUITING

Blusson Spinal Cord Centre, Vancouver

All Listed Sponsors
collaborator

Praxis Spinal Cord Institute

OTHER

lead

University of British Columbia

OTHER